NCT01193231View on ClinicalTrials.gov

A 6 Month Study to Evaluate the Safety, Analgesic Efficacy of ACUVAIL™ (Ketorolac Tromethamine Ophthalmic Solution) 0.45%, in Post-PRK Corneal Wound Healing

CompletedOBSERVATIONAL

Enrollment

10

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

April 30, 2011

Conditions

Must be PRK Candidate

Trial Locations (1)

66211

Durrie Vision, Overland Park

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Allergan

INDUSTRY

lead

Durrie Vision

OTHER

NCT01193231 - A 6 Month Study to Evaluate the Safety, Analgesic Efficacy of ACUVAIL™ (Ketorolac Tromethamine Ophthalmic Solution) 0.45%, in Post-PRK Corneal Wound Healing | Biotech Hunter | Biotech Hunter